Alfonso Zulueta - CTS Independent Director
| CTS Stock | USD 51.09 0.14 0.27% |
Director
Mr. Alfonso G. Zulueta is an Independent Director of the Company. Mr. Zulueta is Senior Vice President of Eli Lilly and Company since 2014. He is President of Lilly International . He is Member of the Executive Committee and Officer of Eli Lilly and Company . He was the President of Emerging Markets and various roles of Eli Lilly and Company since 2018.
| Age | 57 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Address | 4925 Indiana Avenue, Lisle, IL, United States, 60532 |
| Phone | 630 577 8800 |
| Web | https://www.ctscorp.com |
Alfonso Zulueta Latest Insider Activity
Tracking and analyzing the buying and selling activities of Alfonso Zulueta against CTS stock is an integral part of due diligence when investing in CTS. Alfonso Zulueta insider activity provides valuable insight into whether CTS is net buyers or sellers over its current business cycle. Note, CTS insiders must abide by specific rules, including filing SEC forms every time they buy or sell CTS'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Alfonso Zulueta over a year ago Payment of 9674 shares by Alfonso Zulueta of Eli Lilly subject to Rule 16b-3 | ||
Alfonso Zulueta over a year ago Sale by Alfonso Zulueta of 7000 shares of Eli Lilly |
CTS Management Efficiency
The company has Return on Asset of 0.0605 % which means that on every $100 spent on assets, it made $0.0605 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1136 %, implying that it generated $0.1136 on every 100 dollars invested. CTS's management efficiency ratios could be used to measure how well CTS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CTS's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.08 in 2025, whereas Return On Capital Employed is likely to drop 0.10 in 2025. At this time, CTS's Intangible Assets are comparatively stable compared to the past year. Deferred Long Term Asset Charges is likely to gain to about 35.4 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 260.1 M in 2025.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Kenneth Lamneck | Benchmark Electronics | 65 | |
| Bruce Carlson | Benchmark Electronics | 70 | |
| Bruce Crowther | Methode Electronics | 68 | |
| Douglas Duncan | Benchmark Electronics | 70 | |
| Isabelle Goossen | Methode Electronics | 66 | |
| Jeffrey McCreary | Benchmark Electronics | 63 | |
| Robert Gifford | Benchmark Electronics | 62 | |
| Mark Schwabero | Methode Electronics | 67 | |
| John Sheehan | SigmaTron International | 64 | |
| Lawrence Skatoff | Methode Electronics | 80 | |
| Therese Bobek | Methode Electronics | 59 | |
| Angelo Pantaleo | Methode Electronics | 60 | |
| Merilee Raines | Benchmark Electronics | 64 | |
| Darren Dawson | Methode Electronics | 57 | |
| Mary Lindsey | Methode Electronics | 65 | |
| Brian Cadwallader | Methode Electronics | 61 | |
| David Blom | Methode Electronics | 66 | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0605 |
CTS Corporation Leadership Team
Elected by the shareholders, the CTS's board of directors comprises two types of representatives: CTS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CTS. The board's role is to monitor CTS's management team and ensure that shareholders' interests are well served. CTS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CTS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Johnson, Independent Director | ||
| Ye Li, Independent Director | ||
| Scott DAngelo, Vice President General Counsel, Secretary | ||
| Donna Costello, Independent Director | ||
| Luis Machado, Vice President, General Counsel, Secretary | ||
| Michael Murray, Senior President | ||
| Thomas White, Principal Accounting Officer, Controller | ||
| Martin Baumeister, Senior President | ||
| Alfonso Zulueta, Independent Director | ||
| Ashish Agrawal, Chief Financial Officer, Vice President | ||
| Mitchell Walorski, Director Relations | ||
| Robert Profusek, Lead Independent Director | ||
| Gordon Hunter, Independent Director | ||
| Pratik Trivedi, Senior President | ||
| Kieran OSullivan, Chairman, CEO and President and Member of Technology and Transactions Committee |
CTS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CTS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0605 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 1.57 B | ||||
| Shares Outstanding | 30.12 M | ||||
| Shares Owned By Insiders | 1.89 % | ||||
| Shares Owned By Institutions | 99.94 % | ||||
| Number Of Shares Shorted | 384.59 K | ||||
| Price To Earning | 32.42 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CTS Stock Analysis
When running CTS's price analysis, check to measure CTS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTS is operating at the current time. Most of CTS's value examination focuses on studying past and present price action to predict the probability of CTS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTS's price. Additionally, you may evaluate how the addition of CTS to your portfolios can decrease your overall portfolio volatility.